What is the target temperature range for post cardiac arrest patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Target Temperature Management in Post-Cardiac Arrest Patients

For comatose adult patients with return of spontaneous circulation (ROSC) after cardiac arrest, the recommended target temperature range is 32°C to 36°C, maintained for at least 24 hours after achieving target temperature. 1, 2

Patient Selection

  • All comatose (lack of meaningful response to verbal commands) adult patients with ROSC after cardiac arrest should receive targeted temperature management (TTM)
    • Strong recommendation for ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT) out-of-hospital cardiac arrest (OHCA) 1
    • Strong recommendation for non-shockable rhythms and in-hospital cardiac arrest 1

Temperature Selection Within the Range

When selecting a specific temperature within the 32-36°C range:

  • Higher temperatures (36°C) may be preferred for patients with:

    • Bleeding risk 1, 2
    • Coagulopathy concerns
  • Lower temperatures (32-34°C) may be preferred for patients with:

    • Seizures 1, 2
    • Cerebral edema 1, 2
  • Consider the patient's initial temperature:

    • If presenting at the lower end of range, maintain at that temperature
    • If presenting at higher end, maintain at 36°C 1

Implementation Protocol

  1. Induction phase:

    • Do NOT use prehospital cooling with rapid infusion of large volumes of cold IV fluid (Class III: No Benefit) 1, 2
    • This increases risk of re-arrest and pulmonary edema 1, 2
  2. Maintenance phase:

    • Use temperature control devices with feedback systems based on continuous temperature monitoring 1, 2
    • Options include:
      • Water or air circulating blankets/pads
      • Intravascular heat exchangers
      • Surface cooling devices 1
  3. Duration:

    • Maintain target temperature for at least 24 hours 1, 2
    • Even if target temperature isn't achieved, attempt temperature control for at least 24 hours 1
  4. Rewarming phase:

    • Perform controlled rewarming at 0.25-0.5°C per hour 1, 2
    • Avoid rapid rewarming which may worsen neurological outcomes
  5. Fever prevention:

    • After TTM, actively prevent fever (temperature >37.5°C) for 36-72 hours in patients who remain comatose 1, 2
    • Rebound hyperthermia is associated with increased mortality and worse neurological outcomes 1

Monitoring and Complications

During TTM, monitor for and manage:

  • Bradycardia (may be beneficial and associated with good outcomes) 2
  • Electrolyte disturbances
  • Increased vasopressor requirements (more common with lower temperatures) 2
  • Seizures (occur in 12-22% of post-cardiac arrest comatose patients) 2

Prognostication Timing

  • The earliest time for prognostication using clinical examination in patients treated with TTM is 72 hours after normothermia 1, 2
  • Do not rely on clinical criteria alone before this time to estimate prognosis 2

Important Caveats

  • No significant difference in survival or neurological outcomes has been demonstrated between TTM at 33°C versus 36°C in recent high-quality trials 2, 3
  • Avoid actively or rapidly warming patients to higher temperatures within the range 1
  • Allowing temperatures to rise above 36°C is not consistent with current TTM recommendations 1
  • Hyperthermia (>37.5°C) should be actively prevented as it is associated with poor outcomes 1

TTM remains the only potentially neuroprotective intervention recommended for post-cardiac arrest care 4, and should be implemented promptly in all eligible patients to improve neurological outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Targeted Temperature Management in Comatose Patients After Cardiac Arrest

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.